Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases
Where
Chongqing
Age
18 years to 75 years
People
366
Run by
Xinqiao Hospital of Chongqing
See details and how to joinNCT06953843
No phaseTaking people
Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)
Where
Wuhan
Age
18 years and over
People
400
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07059923
No phaseEnrolling by invitation
The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery
Where
Shanghai
Age
18 years to 85 years
People
308
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07060625
Phase 2Taking people
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
Where
Hangzhou
Age
18 years to 75 years
People
20
Run by
Ji Yongling
See details and how to joinNCT06379087
Phase 1Taking people
A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
Where
Hefei
Age
18 years to 75 years
People
20
Run by
Anhui Provincial Hospital
See details and how to joinNCT06232083
Phase 1Taking people
Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors
Where
Tianjin
Age
18 years and over
People
80
Run by
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
See details and how to joinNCT06773507
No phaseTaking people
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
Where
Beijing
Age
18 years and over
People
40
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07057102
Phase 1/2Taking people
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Where
Shanghai
Age
18 years to 70 years
People
40
Run by
Shanghai Public Health Clinical Center
See details and how to joinNCT03093688
No phaseTaking people
Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
Where
Suzhou
People
150
Run by
Zhao Jun
See details and how to joinNCT07047573
Phase 1Taking people
A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation
Where
Guangzhou
Age
18 years to 75 years
People
72
Run by
Jemincare
See details and how to joinNCT06946927
Phase 3Taking people
A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2)
Where
Guangzhou
Age
18 years and over
People
136
Run by
Beijing Pearl Biotechnology Limited Liability Company
See details and how to joinNCT05989542
Phase 2Not yet taking people in China
A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC
Where
Nanjing
Age
18 years to 75 years
People
40
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06977828
No phaseTaking people
Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer
Where
Hefei
Age
65 years and over
People
40
Run by
Anhui Chest Hospital
See details and how to joinNCT07041320
No phaseTaking people
Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer
Where
Guiyang
Age
18 years to 70 years
People
66
Run by
Guizhou Medical University
See details and how to joinNCT05150145
Phase 2Taking people
Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
Where
Shanghai
Age
18 years and over
People
25
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06987734
No phaseTaking people
The Impact of AI Assistance on Radiologist Performance and Healthcare Costs in LDCT-Based Lung Cancer Screening
Where
Guangzhou
Age
40 years to 74 years
People
7,294
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06988579
Phase 2Not yet taking people in China
A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC
Where
Changsha, Guangzhou, Hangzhou
Age
18 years to 75 years
People
134
Run by
Wen-zhao ZHONG
See details and how to joinNCT07038460
No phaseNot yet taking people in China
Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer
Where
Chongqing
Age
18 years and over
People
126
Run by
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07035444
No phaseNot yet taking people in China
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
Where
Hangzhou
Age
18 years to 75 years
People
34
Run by
Ji Yongling
See details and how to joinNCT07035860
Phase 1Not yet taking people in China
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
Where
Shanghai
Age
18 years and over
People
66
Run by
Shanghai Bao Pharmaceuticals Co., Ltd.
See details and how to joinNCT07036185
Phase 3Taking people
SSGJ-707 in Advanced Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
420
Run by
Shenyang Sunshine Pharmaceutical Co., LTD.
See details and how to joinNCT06980272
Phase 2/3Taking people
Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
Where
Tianjin
Age
18 years to 80 years
People
405
Run by
Kong Fanming
See details and how to joinNCT07034326
Phase 2Taking people
A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status
Where
Shenyang
Age
18 years to 75 years
People
40
Run by
China Medical University, China
See details and how to joinNCT07034391
Phase 2Not yet taking people in China
A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer
Where
Xiamen
Age
18 years to 70 years
People
43
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07031154
Phase 2Taking people
DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)
Where
Shanghai
Age
18 years and over
People
60
Run by
Dizal Pharmaceuticals
See details and how to joinNCT06276283